Khiron Targets Peru with Regirstion of Two Medical Cannabis Products
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Canonic Announces the Israeli Pre-Launch of its First-Generation Medical Cannabis Products
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Next Green Wave Awarded Building Permit, Releases Q2 Results
Q2 2021 revenues decreased mainly due to the following non-recurring items: significant shifts in the market for derivatives, at both the retail and wholesale level, the Company adjusted it’s branded product mix deemphasizing edibles, pre rolls and dabbables which resulted in lower overall sales for the quarter. a hardware... Read more
The Name Change is part of a re-branding initiative in order to better align the Company’s name and image as a comprehensive leader in cannabis extraction, distillation and product manufacturing. Following a change in management, the Company decided to proceed with the Name Change for several reasons: (i) “Phyto”... Read more
Bioharvest Sciences Inc. Announces Closing of the First Tranche of Its Private Placement
Ryan Allway August 30th, 2021 News, Top News First tranche closed represents over three-quarters of the anticipated financing. Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 30, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) is pleased to announce that it has closed the first tranche (the “First... Read more
Psychedelic Experience: Treating the Trip that Never Ends
Robin Lefferts August 30th, 2021 Exclusive, News, Psychedelics, Top News Psychedelics, including ketamine, psilocybin, and LSD, are gaining traction in the mental health industry as they have been found to be potentially beneficial for conditions ranging from depression to anxiety to PTSD to alcoholism. As psychedelics are entering the... Read more
Big Data and AI Can Guide Cannabis Medicine
Robin Lefferts August 30th, 2021 App, Exclusive, News, Top Story In order for cannabis medicine to make the big leap to mainstream acceptance, a few things likely have to take place. Doctors, not just cannabis providers, need to become more comfortable discussing and prescribing the plant. Regulations need to... Read more
Top Strike Announces 2021 Fourth Quarter Financial Results, 2021 Annual Financial Results, and Provides Corporate Activity and Update
Ryan Allway August 27th, 2021 CALGARY, AB, Aug. 27, 2021 /PRNewswire/ – Top Strike Resources Corp. d.b.a. “Vencanna Ventures” (the “Corporation” or “Vencanna“) (CSE: VENI) (OTCQB: TPPRF) is pleased to provide a summary of its financial results as of April 30, 2021. Selected financial information is outlined below and should be read... Read more
CEO and Founder of Halo Collective, Kiran Sidhu, commented, “Halo was founded in Oregon, and we believe this is the market of the future as the potential Federal legalization comes to fruition with no cultivation taxes, light local taxation, abundant labor, and water and power at lower rates than most other... Read more
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
Ryan Allway August 26th, 2021 PETACH TIKVA, Israel, August 26, 2021–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended June 30, 2021. Corporate... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )